Intercure
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company has a strategic alliance with… Read more
Market Cap & Net Worth: Intercure (INCR)
Intercure (TA:INCR) has a market capitalization of $35.77 Million (ILA13.34 Billion) as of March 18, 2026. Listed on the TA stock exchange, this Israel-based company holds position #38084 globally and #311 in its home market, demonstrating a -4.46% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Intercure's stock price ILA244.00 by its total outstanding shares 54681335 (54.68 Million).
Intercure Market Cap History: 2015 to 2026
Intercure's market capitalization history from 2015 to 2026. Data shows growth from $22.83 Million to $35.77 Million (4.52% CAGR).
Intercure Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Intercure's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.37x
Intercure's market cap is 0.37 times its annual revenue
1.02x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $22.83 Million | $1.40 Million | -$1.88 Million | 16.29x | N/A |
| 2019 | $241.92 Million | $8.93 Million | -$5.89 Million | 27.10x | N/A |
| 2020 | $239.70 Million | $65.03 Million | -$37.23 Million | 3.69x | N/A |
| 2021 | $303.75 Million | $219.68 Million | $4.69 Million | 1.38x | 64.77x |
| 2022 | $177.09 Million | $388.68 Million | $44.82 Million | 0.46x | 3.95x |
| 2023 | $67.80 Million | $355.55 Million | -$61.96 Million | 0.19x | N/A |
| 2024 | $87.23 Million | $238.84 Million | -$67.80 Million | 0.37x | N/A |
Competitor Companies of INCR by Market Capitalization
Companies near Intercure in the global market cap rankings as of March 18, 2026.
Key companies related to Intercure by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Intercure Historical Marketcap From 2015 to 2026
Between 2015 and today, Intercure's market cap moved from $22.83 Million to $ 35.77 Million, with a yearly change of 4.52%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ILA35.77 Million | -24.46% |
| 2025 | ILA47.35 Million | -45.71% |
| 2024 | ILA87.23 Million | +28.65% |
| 2023 | ILA67.80 Million | -61.71% |
| 2022 | ILA177.09 Million | -41.70% |
| 2021 | ILA303.75 Million | +26.72% |
| 2020 | ILA239.70 Million | -0.92% |
| 2019 | ILA241.92 Million | -26.70% |
| 2018 | ILA330.04 Million | +1267.57% |
| 2017 | ILA24.13 Million | -33.21% |
| 2016 | ILA36.13 Million | +58.29% |
| 2015 | ILA22.83 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Intercure was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $35.77 Million USD |
| MoneyControl | $35.77 Million USD |
| MarketWatch | $35.77 Million USD |
| marketcap.company | $35.77 Million USD |
| Reuters | $35.77 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.